Abbott Laboratories (NYSE: ABT) Has Succeeded In Gaining Momentum In 2024, The Stock Is Down -4.36% YTD
Abbott Laboratories (NYSE:ABT)’s traded shares stood at 7.3 million during the last session, with the company’s beta value hitting 0.75. At the close of trading,